 | ||||||
| car | ||||||
| 网页 | ||||||
| T Cell Biomarker Predicts Which CLL Patients Will Respond to CAR T Cell Therapy Penn Medicine researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia (CLL) don't respond to chimeric antigen receptor (CAR) T cell therapy, and the answer is tied to how primed patients' immune systems are before the therapy is administered.
| ||||||
| 查看更多结果 | 修改此快讯 | ||||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
 以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment